Eli Lilly on Wednesday became the second company to gain approval for a weight-loss pill, as the multibillion-dollar market ...

April 1 (Reuters) - Eli Lilly on Wednesday became the second company to gain approval for a weight-loss pill, as the ...

China's fast-growing market for GLP-1 weight-loss drugs is bracing for a major shake-up as the core compound patent for semaglutide was expiring in March, opening the door for multiple domestic ...

The weight-loss drug market is surging, with biotech firms racing to win share in a sector dominated by Novo Nordisk and Eli ...

The simultaneous patent expiry of Ozempic in China and India has seen generic makers jump in. Low cost production in high ...

China’s BrightGene has served up a slice of early-stage data to remind everyone it has a horse in the oral obesity race.  | ...

U.S. Customs and Border Protection officers in Cincinnati intercepted approximately 5,000 individual shipments of unapproved ...

Patent expiry of blockbuster drug opens door for Chinese drug makers to challenge multinationals in booming weight-loss ...

Can time restricted meals help with weight loss ...

Over the past two years, Eli Lilly (NYSE: LLY) has established itself as the leader in the weight loss market. That's thanks ...

A Utah licensed Osteopathic Physician has been federally indicted after he allegedly received, recommended, and sold ...

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster ...